1. An epidemic of respiratory syncytial virus in elderly people: clinical and serological findings;Agius;J. Med. Virol.,1990
2. Andries, K., Moeremans, M., Gevers, T., Willebrords, R., Lacrampe, J., Janssens, F., 2000. R170591, a novel fusion inhibitor with picomolar activity against respiratory syncytial virus (RSV). In: Proceedings of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada, 17–20 September, 2000 (Abstracts).
3. Andries, K., Moeremans, M., Gevers, T., Willebords, R., Sommen, C., Lacrampe, J., Janssens, F., Wyde, P.R., in press. Substituted benzimidazoles with nanoMolar activity against respiratory syncytial virus. Antivir. Res.
4. Respiratory syncytial virus immune globulin: decisions and cost;Barton;Pediatr. Pulmonol.,2001
5. Committee on Infectious Diseases, 1993. Use of ribavirin in the treatment of respiratory syncytial virus infection. Pediatrics 92, 501–504.